Pharmacokinetics, pharmacodynamics and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in subjects with renal impairment.

First published in Diabetes, Obesity and Metabolism on 2014 Mar.Diabetes Obes Metab. 2014 Mar;16(3):215-22. doi: 10.1111/dom.12182. Epub 2013 Aug 19....
Read Article

Pharmacokinetics of Teneligliptin in Subjects With Renal Impairment.

First published in Clinical Pharmacology in Drug Development on 2013 Jul. Clin Pharmacol Drug Dev. 2013 Jul;2(3):246-54. doi: 10.1002/cpharmacodynamicsd.29. Epub...
Read Article

Impact of impaired renal function on the pharmacokinetics of the antiepileptic drug lacosamide.

First published in Clinical Pharmacokinetics on 2013 Oct.Clin Pharmacokinet. 2013 Oct;52(10):897-906. doi: 10.1007/s40262-013-0080-7. Authors: Cawello W, Fuhr U, Hering U,...
Read Article